相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cross-Talk between Vascular Endothelial Growth Factor and Matrix Metalloproteinases in the Induction of Neovascularization in Vivo
Quteba Ebrahem et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis
Thorsten Berger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis
Xiaohong Leng et al.
CANCER RESEARCH (2009)
Lipocalin 2 A multifaceted modulator of human cancer
Jiang Yang et al.
CELL CYCLE (2009)
Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer
Roopali Roy et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells
Limei Hu et al.
LABORATORY INVESTIGATION (2009)
Lipocalin 2 promotes breast cancer progression
Jiang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia
N. Moniaux et al.
BRITISH JOURNAL OF CANCER (2008)
Neutrophil gelatinase-associated lipocalin: A novel suppressor of invasion and angiogenesis in pancreatic cancer
Zhimin Tong et al.
CANCER RESEARCH (2008)
The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells
Alessio Lannetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer
Maret Bauer et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines
Antoinette Hollestelle et al.
MOLECULAR CANCER RESEARCH (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells
Shivalingappa Venkatesha et al.
MOLECULAR CANCER RESEARCH (2006)
Hypoxia-inducible factor-1 (HIF-1)
Qingdong Ke et al.
MOLECULAR PHARMACOLOGY (2006)
Making the cut: Protease-mediated regulation of angiogenesis
R Roy et al.
EXPERIMENTAL CELL RESEARCH (2006)
A model of human tumor dormancy: An angiogenic switch from the nonangiogenic phenotype
GN Naumov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Neutrophil gelatinase-associated lipocalin as a survival factor
ZM Tong et al.
BIOCHEMICAL JOURNAL (2005)
On mouse and man: neutrophil gelatinase associated lipocalin is not involved in apoptosis or acute response
P Klausen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients
CA Fernández et al.
CLINICAL CANCER RESEARCH (2005)
Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2) -: Loop 6 is a novel angiogenesis inhibitor
CA Fernández et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells
R Fukuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL) - Modulation of MMP-9 activity by NGAL
L Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
